Search - tctmd.com

Displaying 121 - 140 of 531

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Presenter: William A. Gray, Gregg W. Stone, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Presenter: William A. Gray, Gregg W. Stone, Matthew J. Price

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Random Musings on TMVR Pivotal Trial Designs

Presenter: Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Presenter: Martin B. Leon, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

Presenter: Martin B. Leon, Gregg W. Stone, Michael J. Mack

June 22, 2018

Presentation Fellows 2018

NSTEMI Case Presentations With Discussion

Presenter: Duane S. Pinto, Ajay J. Kirtane, Nicholas J. Lembo, Jeffrey W. Moses, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

ACS Pharmacology for the Interventionalist

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

The History of Reperfusion Therapies in STEMI: How Far Weve Come

Presenter: Duane S. Pinto, Gregg W. Stone

April 13, 2018

Presentation Fellows 2018

The Evolution of Drug-Eluting Stents

Presenter: Manish A. Parikh, Gregg W. Stone

April 13, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

Presentation JIM 2018

Overview of New Generation Drug-Eluting Stents

Presenter: Gregg W. Stone

February 22, 2018

Presentation CTO 2018

Decision CTO, EURO CTO, OPEN CTO

Presenter: Gregg W. Stone, Ajay J. Kirtane

February 16, 2018

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata

November 01, 2017

Advertisement

Updated Amulet Outcomes and Ongoing Studies in Anticoagulant Indicated and Contraindicated Patients

Updated Watchman Results in Anticoagulant Indicated and Contraindicated Patients: Randomized Trials and Registries

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Random Musings on TMVR Pivotal Trial Designs

Interventional Perspectives of TMVR: Addressing the Four Big Questions

Surgical Perspectives of TMVR: Focus on Patient Selection and Clinical Management Issues

NSTEMI Case Presentations With Discussion

ACS Pharmacology for the Interventionalist

The History of Reperfusion Therapies in STEMI: How Far Weve Come

The Evolution of Drug-Eluting Stents

Update on PCI for LMCA and Multivessel Disease

Overview of New Generation Drug-Eluting Stents

Decision CTO, EURO CTO, OPEN CTO

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content